Search results for "neuroblastoma."

showing 10 items of 238 documents

High levels of HIF-2α highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche

2007

High HIF-2alpha protein levels in the sympathetic nervous system-derived childhood tumour neuroblastoma as well as immature phenotype correlate to unfavourable outcome. Here we show that a small subset of perivascularly located, strongly HIF-2alpha-positive tumour cells (MYCN amplified) lacks expression of differentiation markers, but expresses neural crest and early sympathetic progenitor marker genes such as Notch-1, HES-1, c-Kit, dHAND, and vimentin. HIF-2alpha- and CD68-positive tumour-associated macrophages were frequently found close to the immature and HIF-2alpha-positive neuroblastoma cells and as VEGF levels are high in the perivascular niche, we hypothesize that neuroblastoma neur…

Vascular Endothelial Growth Factor APathologymedicine.medical_specialtySympathetic Nervous SystemAngiogenesisVimentinPathology and Forensic MedicineNeuroblastomaNeuroblastomaBasic Helix-Loop-Helix Transcription FactorsTumor Cells CulturedmedicineHumansMacrophageProgenitorOncogene ProteinsN-Myc Proto-Oncogene ProteinNeovascularization PathologicbiologyMacrophagesNuclear ProteinsNeural crestmedicine.diseasePhenotypeCell HypoxiaNeoplasm ProteinsNeural CrestNeoplastic Stem Cellsbiology.proteinCancer researchStem cellThe Journal of Pathology
researchProduct

Lack of association betweenMDM2promoter SNP309 and clinical outcome in patients with neuroblastoma

2014

While a polymorphism located within the promoter region of the MDM2 proto-oncogene, SNP309 (T > G), has previously been associated with increased risk and aggressiveness of neuroblastoma and other tumor entities, a protective effect has also been reported in certain other cancers. In this study, we evaluated the association of MDM2 SNP309 with outcome in 496 patients with neuroblastoma and its effect on MDM2 expression. No significant difference in overall or event-free survival was observed among patients with neuroblastoma with or without MDM2 SNP309. The presence of SNP309 does not affect MDM2 expression in neuroblastoma. Pediatr Blood Cancer 2014; 61:1867–1870. © 2014 Wiley Periodicals,…

biologybusiness.industryMdm2 snp309PromoterSingle-nucleotide polymorphismHematologymedicine.diseaseenzymes and coenzymes (carbohydrates)OncologyNeuroblastomaPediatrics Perinatology and Child HealthGenotypebiology.proteinCancer researchMedicineMdm2In patientbusinessneoplasmsGenotypingPediatric Blood & Cancer
researchProduct

Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options

2019

The majority of embryonal tumors or childhood blastomas derive from pluripotent progenitors or fetal stem cells that acquire cancer stem cell (CSC) properties: multipotency, self-renewal ability, metastatic potential, chemoresistance, more pronounced levels of drug transporters, enhanced DNA-damage repair mechanisms, and a quiescent state. Neuroblastoma (NB) is considered a neuroendocrine tumor and is the most common extracranial neoplasm in children. NB pathogenesis has frequently been associated with epigenetic dysregulation and a failure to implement a differentiation program. The origin, characteristics, and isolation of the CSC subpopulation in NB are still incompletely understood, des…

cancer stem cells0301 basic medicinecancer stem cellEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismStem cell factorReviewBiologylcsh:Diseases of the endocrine glands. Clinical endocrinologySTAT303 medical and health sciencesneuroblastomaEndocrinology0302 clinical medicineCancer stem cellNeuroblastomamedicineanti-cancer therapiesProgenitor cellFetal Stem Cellsmesenchymal stem cellmesenchymal stem cellsTumor microenvironmentlcsh:RC648-665Mesenchymal stem cellanti-cancer therapiemedicine.disease030104 developmental biologyCancer researchReprogramming
researchProduct

Anticancer study of heterobimetallic platinum(II)-ruthenium(II) and platinum(II)-rhodium(III) complexes with bridging dithiooxamide ligand

2019

Abstract Three heterobimetallic platinum (II)/ruthenium (II) and platinum (II)/rhodium (III) complexes, A: Pt{S–S2C2(NR)2H}{μ-S2C2(NR)2}-[Ru (p-cymene)Cl], R = isoamyl; B: Pt{S–S2C2(NR)2H}{μ-S2C2(NR)2}[Rh (phpy)2], R = isoamyl; C: [Pt{S–S2C2(NR)2H}{μ-S2C2(NR)2}-[Rh(C5Me5)Cl]], R = benzyl, were prepared from mononuclear complexes 1 and 2, 1: [Pt (H-isoamyl2DTO)2]; 2: [Pt (H-benzyl2DTO)2], DTO = dithiooxamide, by reaction of 1 or 2 with the corresponding chlorido-bridged dimers, [Rh(C5Me5)Cl (μ-Cl)]2, [Ru (p-cymene)Cl (μ-Cl)]2 or [Rh (phpy)2 (μ-Cl)]2, and then evaluated as anticancer agents for the inhibition of the three proteolytic activities of human 20S proteasome, one of the main target …

chemistry.chemical_classification010405 organic chemistryChemistryOrganic Chemistrychemistry.chemical_element010402 general chemistrymedicine.disease01 natural sciencesBiochemistryMedicinal chemistry0104 chemical sciencesRhodiumRutheniumAnticancer; Dithiooxamide; Heterobimetallic; Platinum complexes; Rhodium; RutheniumInorganic Chemistrychemistry.chemical_compoundEnzymeDithiooxamideApoptosisNeuroblastomaMaterials ChemistrymedicinePhysical and Theoretical ChemistryPlatinumCytotoxicityJournal of Organometallic Chemistry
researchProduct

Development of an in vitro neuroblastoma 3D model and its application for sterigmatocystin-induced cytotoxicity testing

2021

Abstract Given the increasing importance of establishing better risk assessments for mycotoxins, novel in vitro tools for the evaluation of their toxicity are mandatory. In this study, an in vitro 3D spheroid model from SH-SY5Y cells, a human neuroblastoma cell line, was developed, optimized and characterized to test the cytotoxic effects caused by the mycotoxin sterigmatocystin (STE). STE induced a concentration- and time-dependent cell viability decrease in spheroids. Spheroids displayed cell disaggregation after STE exposure, increasing in a dose-dependent manner and over time. STE also induced apoptosis as confirmed by immunofluorescence staining and Western blot. Following the decrease…

endocrine systemCytotoxicitySterigmatocystinBlotting WesternCellFluorescent Antibody TechniqueToxicology3D cell culturechemistry.chemical_compoundNeuroblastomaCell MovementCell Line TumorSpheroids CellularMechanisms of actionToxicity TestsmedicineHumansCell Culture Techniques Three DimensionalViability assayCytotoxicityChemistryGeneral MedicineMycotoxins3D spheroidCytostasisCell biologymedicine.anatomical_structure3D spheroid; Cytotoxicity; Mechanisms of action; Neuroblastoma; SterigmatocystinCell cultureApoptosisComet AssayReactive Oxygen SpeciesFood ScienceSterigmatocystin
researchProduct

Retinoids as a Perspective in Treatment of Alzheimer’s Disease

2010

<i>Background:</i> In the past, we demonstrated that the disintegrin metalloproteinase ADAM10 has α-secretase activity in vitro and in cultured cells. We also found out that moderate overexpression of this proteinase inhibits Aβ peptide production and prevents the formation of amyloid plaques in an Alzheimer’s disease (AD) mouse model. Moreover, it corrects early hippocampal defects like LTP impairment and increases cortical synaptogenesis. <i>Objective:</i> Upregulation of ADAM10 might be an alternative approach concerning AD therapy. Our current research therefore focuses on substances and/or pathways which regulate ADAM10 gene expression. <i>Methods:</i&g…

endocrine systemMorpholinesADAM10DiseaseBiologyADAM10 ProteinMiceNeuroblastomaRetinoidsPromoter activityCell Line TumorDisintegrinAnimalsHumansEnzyme InhibitorsMetalloproteinaseDose-Response Relationship DrugTerpenesPerspective (graphical)Membrane ProteinsVitaminshumanitiesIn vitroUp-Regulationcarbohydrates (lipids)ADAM ProteinsNeurologyChromonesImmunologyCancer researchbiology.proteinNeurology (clinical)Amyloid Precursor Protein SecretasesSignal TransductionNeurodegenerative Diseases
researchProduct

Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma

2010

Abstract Background Cancer genomes display characteristic patterns of chromosomal imbalances, often with diagnostic and prognostic relevance. Therefore assays for genome-wide copy number screening and simultaneous detection of copy number alterations in specific chromosomal regions are of increasing importance in the diagnostic work-up of tumors. Results We tested the performance of Multiplex Amplicon Quantification, a newly developed low-cost, closed-tube and high-throughput PCR-based technique for detection of copy number alterations in regions with prognostic relevance for neuroblastoma. Comparison with array CGH and the established Multiplex Ligation-dependent Probe Amplification method…

lcsh:QH426-470DNA Copy Number Variationslcsh:BiotechnologyCopy number analysisARRAY CGHBiologyProteomicsGenomePolymerase Chain Reactionlaw.inventionNeuroblastomalawlcsh:TP248.13-248.65GeneticsMedicine and Health SciencesHumansSUBGROUPSMultiplexBiologyPolymerase chain reactionDEMENTIANucleic acid amplification techniqueAmpliconMolecular biologylcsh:GeneticsHuman medicineDNA microarrayNucleic Acid Amplification TechniquesBiotechnologyResearch Article
researchProduct

Metastatic neuroblastoma to the mandible in a 3-year-old boy : a case report

2007

Although neuroblastoma is a relatively common malignancy of childhood and its dissemination to distant organs is often seen, metastasis to the mandible is rare. A 3-year-old boy which a mandibular soft tissue mass was the initial presenting symptom of disseminated neuroblastoma is reported. The results of biopsy were inconclusive and the differential diagnosis from the imaging studies included lymphoma, soft tissue sarcoma, and osteosarcoma. A metastatic work-up disclosed neuroblastoma of the adrenal gland origin with osseous and bone marrow metastases. Urinary catecolamines were also increased. Regarding the widespread features of the tumor and lack of adequate treatment at this stage of d…

mandibleNeuroblastomaUNESCO::CIENCIAS MÉDICASmetastasis:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Pigmented esthesioneuroblastoma showing dual differentiation following transplantation in nude mice

1989

Esthesioneuroblastoma (ESTH) is a neuroepithelial-cell-derived neoplasm of the olfactory mucosa composed of homogeneous small round cells which contain neurosecretory granules. Melanin has been detected in such tumours only occasionally. Here we describe a new case of ESTH with divergent differentiation. The primary neoplasm was found in a 67 year-old female, involving the left nasal and maxillary sinus; she died of cerebral metastasis ten months after diagnosis. Histologically only small round cells were seen, with S-100 and NSE positivity. Electron microscopy revealed neurosecretory granules and filaments, as well as the occasional presence of melanosomes. A nude mice xenograft line has b…

medicine.medical_specialtyCell typePathologyTransplantation HeterologousMice NudeBiologyPathology and Forensic MedicineMiceOlfactory mucosaEsthesioneuroblastomaTumor Cells CulturedmedicineAnimalsHumansNeuroectodermal Tumors Primitive PeripheralMolecular BiologyAgedChromosome AberrationsChromosome 7 (human)Olfactory NeuroblastomaCytogeneticsCell BiologyGeneral Medicinemedicine.diseaseImmunohistochemistryPrimary NeoplasmTransplantationMicroscopy Electronmedicine.anatomical_structureFemaleNeoplasm TransplantationVirchows Archiv A Pathological Anatomy and Histopathology
researchProduct

Retroperitoneal neuroblastomas - a single institution experience in 90 patients

2007

Purpose Nowadays neuroblastomas are detected incidentally by ultrasound in early stages. Primary surgery, chemotherapy and/or radiotherapy are treatment options. However, the approach in babies is controversial. A surveillance strategy is propagated by some groups. In this retrospective study, we evaluated age and stage at diagnosis, therapy and outcome of patients treated at our institutions since 1970. Material and methods 90 patients with retroperitoneal neuroblastomas were treated. They were divided into 2 groups according to age at time of diagnosis:  1 year. Results 40 patients were  1 year (1- 18 years). Detection of an asymptomatic tumour:  1 year 10%. Tumor stage at diagnosis > 1 y…

medicine.medical_specialtyChemotherapybusiness.industryUrologymedicine.medical_treatmentRetrospective cohort studyDiseasemedicine.diseaseAsymptomaticSurgeryRadiation therapyNeuroblastomaPediatrics Perinatology and Child HealthmedicineSingle institutionmedicine.symptomStage (cooking)businessJournal of Pediatric Urology
researchProduct